$25.46 0.30 (+1.19%)
12/4/2009 10:51 AM

Bristol-Myers Squibb Co. (BMY)

CAPS Rating: 4 out of 5

The Company, through its divisions and subsidiaries, is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and other health care related products.

Recs

3
Member Avatar manchesteruk (< 20) Submitted: 10/5/2006 3:30:14 AM : Underperform Start Price: $21.24 BMY Score: -31.47

only potential M&A make this stock attractive

Report this Post 1 Comment
Member Avatar johnsloan (96.79) Submitted: 11/2/2006 12:17:54 PM
Recs: 0 Rec This

that is a big attraction

Report this Post

Featured Broker Partners